Supplemental Figure 2

Published: 28 August 2020| Version 1 | DOI: 10.17632/929v4rjvdt.1
Contributor:
Chiaki Murase

Description

Supplemental Figure 2. Serum IgE and TARC levels before and after the treatment with dupilumab. A, serum IgE, B, serum thymus and activation-regulated chemokine (TARC). Serum IgE (A) and TARC (B) levels were calculated for 6 months from the initial administration of the dupilumab treatment. Serum IgE and TARC levels decreased significantly after the treatment.

Files

Categories

Prospective Study

Licence